These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19412915)

  • 41. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.
    Lai J; Syngelaki A; Poon LC; Nucci M; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):149-55. PubMed ID: 23154616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.
    Giguère Y; Massé J; Thériault S; Bujold E; Lafond J; Rousseau F; Forest JC
    BJOG; 2015 Feb; 122(3):402-10. PubMed ID: 25175335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.
    Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.
    Nicolaides KH; Bindra R; Turan OM; Chefetz I; Sammar M; Meiri H; Tal J; Cuckle HS
    Ultrasound Obstet Gynecol; 2006 Jan; 27(1):13-17. PubMed ID: 16374755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia.
    Yu CK; Lakasing L; Papageorghiou AT; Spencer K; Nicolaides KH
    J Matern Fetal Neonatal Med; 2004 Aug; 16(2):134-9. PubMed ID: 15512726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TNF-R1 as a first trimester marker for prediction of pre-eclampsia.
    E Holanda Moura SB; Park F; Murthi P; Martins WP; Kane SC; Williams P; Hyett J; da Silva Costa F
    J Matern Fetal Neonatal Med; 2016 Mar; 29(6):897-903. PubMed ID: 25758630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal serum human placental growth hormone (hPGH) at 11 to 13 weeks of gestation in preeclampsia.
    Sifakis S; Akolekar R; Mantas N; Kappou D; Nicolaides KH
    Hypertens Pregnancy; 2011; 30(1):74-82. PubMed ID: 20818952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
    Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.
    Sartori MT; Serena A; Saggiorato G; Campei S; Faggian D; Pagnan A; Paternoster DM
    J Thromb Haemost; 2008 Feb; 6(2):352-8. PubMed ID: 18021302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of recurrent preeclampsia using first-trimester uterine artery Doppler.
    Demers S; Bujold E; Arenas E; Castro A; Nicolaides KH
    Am J Perinatol; 2014 Feb; 31(2):99-104. PubMed ID: 23508700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
    Akolekar R; de Cruz J; Foidart JM; Munaut C; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):191-7. PubMed ID: 20101671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
    Birdir C; Fryze J; Vasiliadis H; Nicolaides KH; Poon LC
    J Matern Fetal Neonatal Med; 2015 May; 28(8):865-8. PubMed ID: 24953352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early Prediction of Hypertensive Disorders of Pregnancy Using Cell-Free Fetal DNA, Cell-Free Total DNA, and Biochemical Markers.
    Kim SY; Kim HJ; Park SY; Han YJ; Choi JS; Ryu HM
    Fetal Diagn Ther; 2016; 40(4):255-262. PubMed ID: 26998901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. OS084. Maternal haemodynamics at 11-13 weeks of gestation and adverse pregnancy outcomes.
    Khalil A; Akolekar R; Syngelaki A; Elkhouli M; Nicolaides K
    Pregnancy Hypertens; 2012 Jul; 2(3):223-4. PubMed ID: 26105297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ADAM12s in maternal serum as a potential marker of pre-eclampsia.
    Spencer K; Cowans NJ; Stamatopoulou A
    Prenat Diagn; 2008 Mar; 28(3):212-6. PubMed ID: 18264967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OS088. First trimester triple vascular test for pre-eclampsia prediction.
    Alves JA; Brennecke SP; da Silva Costa F
    Pregnancy Hypertens; 2012 Jul; 2(3):226. PubMed ID: 26105303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First-trimester maternal factors and biomarker screening for preeclampsia.
    Poon LC; Nicolaides KH
    Prenat Diagn; 2014 Jul; 34(7):618-27. PubMed ID: 24764257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
    Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
    Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.
    Gallo D; Poon LC; Fernandez M; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):28-37. PubMed ID: 24752037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.